| Kolb, Edward Anders |
Alfred I. Du Pont Hosp For Children
United States |
Nemours NCI Community Oncology Research Program (NCORP) |
5UG1CA189958-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Krause, Diane S |
Yale University
United States |
"Exploration of Human Parathyroid Cellular Organization and Function" |
1R21CA240660-01A1 |
|
Cecilia Lee, Dr.P.H., R.N. |
| Kroetz, Deanna L |
University Of California, San Francisco
United States |
Contribution of Nuclear S1P Signaling to Microtubule Targeting Agent-Induced Changes in Transcriptional Activity in Human iPS-SNs |
3R01CA261068-02S1 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Lad, Thomas |
Hektoen Institute For Medical Research
United States |
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal |
5UG1CA190000-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Ladas, Elena J. |
Columbia University Health Sciences
United States |
Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer |
5R01CA201788-07 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Langevin, Anne-Marie R. |
University Of Texas Hlth Science Center
United States |
Texas Pediatric NCORP MU |
5UG1CA189855-09 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Lee, Richard T |
Beckman Research Institute/City Of Hope
United States |
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy |
1R21CA260447-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Lesser, Glenn J |
Wake Forest University Health Sciences
United States |
Clinical Studies NCORP Boot Camp Program for Early-Career Investigators |
3UG1CA189824-09S2 |
|
Worta McCaskill-Stevens, M.D., M.S. |
| Levine, Jon David |
University Of California, San Francisco
United States |
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress |
5R01CA250017-04 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Lin, Po-Ju |
University Of Rochester
United States |
Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy |
1R21CA256154-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |